Investment Analysts’ Updated EPS Estimates for September 22nd (ABVX, ALKS, AM, ATLANTIC, ATLC, BEAT, BRBY, BUR, CWK, DAVA)
Investment Analysts’ updated eps estimates for Tuesday, September 22nd: Abivax (NASDAQ:ABVX) had its overweight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $148.00 target price on the stock. Alkermes (NASDAQ:ALKS) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $56.00 price […]
22 Sep 17:44 · The Markets Daily